Sign in

Private company

Miltenyi Biotec

Logo: Alesskon, CC BY-SA 4.0, via Wikimedia Commons3

Global biotechnology company

Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services for scientists, clinical researchers, and physicians to use in their basic research, translational research, and clinical applications. These services include techniques of sample preparation, cell separation, cell sorting, flow cytometry, spatial biology, cell culture, molecular analysis, clinical applications and small animal imaging.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1989Founded1

See how the biggest companies compare on our leaderboards

Miltenyi Biotec is a global biotechnology company headquartered near Cologne in Bergisch Gladbach, Germany. The company is a provider of products and services for scientists, clinical researchers, and physicians to use in their basic research, translational research, and clinical applications. These services include techniques of sample preparation, cell separation, cell sorting, flow cytometry, spatial biology, cell culture, molecular analysis, clinical applications and small animal imaging. According to Miltenyi Biotec own internal sources, the company states that it has over 3,000 employees in 28 countries and produces more than 17,000 products although this has not been independently verified.2

The story

1989 – Stefan Miltenyi invents magnetic-activated cell separation

1990 – Miltenyi Biotec patents MACS Technology

1992 – Miltenyi Biotec opens its U.S. subsidiary

1995 – Miltenyi Biotec opens its UK subsidiary

1998 – Miltenyi Biotec opens its France, Italy and Spain subsidiaries

2001 – Miltenyi Biotec opens its China location

2002 – Miltenyi Biotec acquires the plasma absorber technology developed by PlasmaSelect AG and markets the products under the trademark TheraSorb

2002 – Miltenyi Biotec opens its Australia subsidiary

Read the full text

2003 – Miltenyi Biotec opens its GMP facility in Teterow, Germany

2003 – Miltenyi Biotec opens its Japan and Singapore subsidiaries

2003 – Miltenyi Biotec acquires Memorec Biotec GmbH

2004 – Miltenyi Biotec opens its Benelux subsidiary in the Netherlands

2008 – Miltenyi Biotec acquires Medic Tools AG

2008 – Miltenyi Biotec launches its autoMACS Pro Separator cell separation instrument

2008 – Miltenyi Biotec launches its MACSQuant Analyzer flow cytometry instrument

2011 – Miltenyi Biotec acquires Coley Pharmaceutical Group

2011 – Miltenyi Biotec partners with TeutoCell to develop novel cell culture techniques

2012 – Miltenyi Biotec opens its Nordic subsidiary in Sweden

2012 – Miltenyi Biotec opens its Korea subsidiary in Seoul, South Korea

2013 – Miltenyi Biotec acquires Owl biomedical, adding to their portfolio new microchip-based cell sorting technology

2014 – Miltenyi Biotec receives FDA approval for CliniMACS® CD34 Reagent System for prevention of graft-versus-host disease in the treatment of acute myeloid leukemia

2014 – Miltenyi Biotec acquires gene therapy assets from Lentigen Corporation

2017 – Acquisition of imaging specialist Sensovation AG

2018 – Acquisition of microscopy specialist LaVision BioTec

From Wikipedia’s article on Miltenyi Biotec, shared under CC BY-SA 4.0.4

Products and brands

Miltenyi Biotec states that their products have been cited in publications and used in clinical treatments although details on figures has not been independently verified. However, publications that have cited Miltenyi Biotec products can be accessed through CiteAb, an antibody search engine which lists 4591 Miltenyi Biotec products.

Miltenyi Biotec instruments, reagents and services are intended support basic research, clinical research, and the translation of basic research findings into clinical applications that aims to treat severe diseases. Services offered by Miltenyi Biotec include gene expression analysis and contract production of biologicals according to GMP guidelines.

Miltenyi Biotec technologies are used in applications concerned with accessing, analyzing, and utilizing primary and primary-derived cells – across basic research, translational research, and clinical applications. Examples of these applications include sample preparation, cell separation, cell sorting, flow cytometry, molecular applications, cell culture up to GMP grade, preclinical imaging, clinical-grade cell preservation, and clinical-scale cell processing. The company’s reagents and devices are used primarily in the research areas of immunology, stem cell biology, neuroscience and cancer.

Sample Preparation

Miltenyi Biotec offers instruments, tools and reagents to facilitate sample preparation.

From Wikipedia’s article on Miltenyi Biotec, shared under CC BY-SA 4.0.4

Timeline

  1. 1989Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4